USPTO 2015–2025 USPTO PatentsView US Corporation

Arthrex, Inc.

USPTO PatentsView assignee record - 526 granted patents across 56 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

526

Total patents granted

CPC technology areas

15.9

Avg claims per patent

+29%

5-year filing velocity

The verdict

Arthrex holds 526 US patents across 56 technology areas, rank #859 of 50,000 tracked assignees.

#859
of 50,000 US assignees by volume: Top 3%
by Innovation Score (62.0/100): 15.9
avg claims per patent: +29%
filing velocity, last 5 yrs

Portfolio overview

Arthrex, Inc. has been granted 526 US utility patents between 2015 and 2025, placing Arthrex, Inc. at rank #859 across all assignees tracked by PlainPatent. This portfolio spans 56 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Arthrex, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Arthrex sits between Medtronic Vascular, Inc. (533 patents, rank #855) and Echostar Technologies L.l.c. (525 patents, rank #863) - the closest US assignees by grant volume. The composite Innovation Score of 62.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 296 grants, compared with 230 in the 2015–2019 window, a +29% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Arthrex, Inc.'s 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 56 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Arthrex, Inc. against peers pursuing similar technology classes.

Medtronic Vascular

533
Nuflare Technology

533
Micro Focus

532
Waters

531
Johnson Matthey P…

526
Lyft

526
Xiaomi

526
Arthrex ◀

526
Echostar L L C

525

What this shows Arthrex holds 526 patents at rank #859, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arthrex

By rank, the assignees closest to #859 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Arthrex's primary technology class.

Arthrex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Arthrex, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	41	7.8%
2016	40	7.6%
2017	39	7.4%
2018	53	10.1%
2019	57	10.8%
2020	57	10.8%
2021	47	8.9%
2022	43	8.2%
2023	54	10.3%
2024	42	8.0%
2025	53	10.1%

Which technologies does Arthrex, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 468

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 211

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 34

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 15

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 15

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 12

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 10

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 9

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 8

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 7

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 6

C12Y - ENZYMES 4

B01D - SEPARATION 4

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 4

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 4

Top 15 of 56 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#859

Across all tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Arthrex, Inc. hold?

Arthrex, Inc. holds 526 US granted patents filed between 2015 and 2025, spanning 56 technology areas.

What is Arthrex, Inc.'s Innovation Score?

Arthrex, Inc. has an Innovation Score of 62.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arthrex, Inc. focus on?

Arthrex, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 468 patents. The company has filed patents in 56 CPC subclasses total.

Is Arthrex, Inc.'s patent filing rate increasing or decreasing?

Arthrex, Inc.'s recent filing velocity is +29% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Arthrex, Inc.'s patents?

Arthrex, Inc.'s patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Arthrex, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Arthrex's 526 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Arthrex ranks #859 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.